SCHEMBL24310785

SCHEMBL24310785

Cc1cccc(C)c1-c1cc(Oc2ccc(N3CCC(O)CC3)cc2)nc(NSc2cnn(C)c2)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 4/20 0.34
▸ MET P08581 2/20 0.33
▸ IRAK1 P51617 2/20 0.33
▸ JAK2 O60674 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ DCLK1 O15075 2/20 0.32
▸ LRRK2 Q5S007 2/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ PIK3CA P42336 1/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.31
▸ MAPK8 P45983 1/20 0.30
▸ EGLN1 Q9GZT9 1/20 0.30
▸ PDE3B Q13370 1/20 0.30
▸ PDE3A Q14432 1/20 0.30
▸ PTK2 Q05397 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ TYK2 P29597 1/20 0.30
▸ ABL1 P00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310202 0.89 PLK4 (0.38) MAP4K1METJAK2PIK3CAKDM4E
SCHEMBL24310587 0.89 FLT3 (0.37) MAP4K1JAK3PIM1MAPK8
SCHEMBL24310548 0.86 PLK4 (0.36) MAP4K1METPIK3CAKDM4EALDH1A1
SCHEMBL24310347 0.84 GPR39 (0.39) KDM4EALDH1A1
SCHEMBL24310563 0.84 HPGD (0.31) —
SCHEMBL24310172 0.84 MAP4K1 (0.36) MAP4K1
SCHEMBL26812335 0.83 JAK2 (0.36) MAP4K1IRAK1JAK2JAK3DCLK1
SCHEMBL24310126 0.82 AURKA (0.36) MAP4K1ALDH1A1
SCHEMBL24310142 0.82 GPR39 (0.30) —
SCHEMBL24309516 0.82 FLT3 (0.35) METMAPK8PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback